Business

Rockwell Medical Announces Second Quarter 2025 Results

WIXOM, Mich., August 14, 2025--Rockwell Medical announces financial and operational results for the three and six months ended June 30, 2025.

articleRockwell Medical, Inc.August 14, 202512/company/rockwell-medical-inc/news/rockwell-medical-announces-second-quarter-100000930
Rockwell Medical Announces Second Quarter 2025 Results

About this update from Rockwell Medical, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":400,"url":"https://media.zenfs.com/en/business-wire.com/e0005dbd1ece54a45ee7c070d806942b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/lrss07K7Bv.4HawzK3eMZQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTcwNTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/e0005dbd1ece54a45ee7c070d806942b","width":400,"height":400}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Generated $1.8 million in cash flow from operations for the second quarter of 2025.","length":83,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Reported gross margin of 16% for the second quarter of 2025, in line with 2025 guidance.","length":88,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Increased cash position at June 30, 2025 to $18.4 million.","length":58,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":229,"olType":false},{"type":"text","content":"WIXOM, Mich., August 14, 2025--(BUSINESS WIRE)--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced financial and operational results for the three and six months ended June 30, 2025.","length":364,"tagName":"p"},{"type":"text","content":""During the second quarter of 2025, we successfully managed through the transition of our largest customer away from Rockwell Medical and now find ourselves at a steady state, which we believe positions us well for continued growth," said Mark Strobeck, Ph.D., Rockwell Medical’s President and CEO. "Our long-standing reputation for high-quality products, a reliable supply chain, and excellent customer service continues to differentiate Rockwell Medical in an ever-changing, dynamic marketplace. We continue to bring on new customers, both domestically and internationally, and are actively renewing contracts with existing customers. Today, more than 80% of our customers are under long-term contracts. Furthermore, we are managing our expenses and manufacturing our products more cost effectively to improve gross margin and drive profitability on an Adjusted EBITDA basis....

More updates from Rockwell Medical, Inc.

Rockwell MedicalGross Profitgross margin